GlaxoSmithKline, Emergent BioSolutions test Ebola vaccines

Posted by Leanne Kodsman on

According to FierceBiotech's March 18 article, GlaxoSmithKline (GSK) is testing out an Ebola vaccine in Africa. It is interested to find out if an immune reaction strong enough to overcome Ebola will occur.

If no strong immune response occurs, GSK will test Emergent BioSolutions' Ebola shot as a booster to their own vaccination. The two companies have partnered in this endeavor in Phase I trials at the University of Oxford.


According to FierceBiotech's March 18 article, GlaxoSmithKline (GSK) is testing out an Ebola vaccine in Africa. It is interested to find out if an immune reaction strong enough to overcome Ebola will occur.

If no strong immune response occurs, GSK will test Emergent BioSolutions' Ebola shot as a booster to their own vaccination. The two companies have partnered in this endeavor in Phase I trials at the University of Oxford.

Emergent, based in Maryland, announced that through partnerships with several different companies it was able to create an Ebola candidate called a modified vaccinia Ankara Ebola Zaire vaccine, or MVA EBOZ.

Emergent's candidate was produced using a scalable process which means it could be mass produced to meet demands for large numbers of doses.

Only Merck and NewLink are currently testing their candidates in Africa.


    Innovative Research was established in 1998 after the realization that dependable, high-quality, and affordable research materials were hard to come by. Starting with core products like human plasma and serum, Innovative Research has grown to be a trusted supplier of all lab reagents, including human biologicals and ELISA kits. Today, we manufacture and supply thousands of high-quality human and animal biologicals including plasma, serum, tissues, and proteins.


Related Posts

Antigen, Abbreviated: Factor IX
What is Factor IX and what does it do? Factor IX, also referred to as Christmas Factor ...
Read the Article
Case closed? Genetic testing provides insight into unexplained sudden deaths of Amish children
An Amish family suffered a sudden and tragic event when one of their children died sudd...
Read the Article
PAI-1 Mutation in Amish Community Could Lead to New Treatments for Age-Related Disorders
In the early 1990s, a paper was published in the New England Journal of Medicine that d...
Read the Article

← Older Post Newer Post →